What is CHMMD?
Chimeric Therapeutics Limited, a clinical stage cell therapy company, develops and commercializes a range of cell therapies for oncology in Australia.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
Chimeric Therapeutics Limited, a clinical stage cell therapy company, develops and commercializes a range of cell therapies for oncology in Australia. The company develops CHM CDH17-directed CAR T cell therapy for the treatment of advanced colorectal cancer, gastric cancer, and intestinal neuroendocrine tumors; and CHM CLTX, a chlorotoxin-directed CAR T cell therapy to treat patients with recurrent or progressive glioblastoma and membrane-bound matrix metalloproteinase-2 (MMP2) expressing solid tumors. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 5.18M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.